Ariad Pharmaceuticals Inc
update 05/17
16.67
0.20 (1.21%%)
TODAY
High 16.85
Low 16.40
Open 16.66
Volume 3261521
Time 05/17
52 WEEK SUMMARY
High 25.40
Low 15.13
P/E 0.00
Return
4.31%
Mkt Cap
3.079 B
ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=643900774&utmp=%2Fquote%2FARIA%3AUS&utmhn=10.248.179.17&utmac=UA-11413116-12&utmhid=370114071)